Abstract
Background
Low molecular weight heparins (LMWHs) are currently used as a standard for anti-thrombotic therapy. Skin necrosis caused by LMWH is a rare and probably under-reported complication. The aim of our systematic review is to analyse the present literature for cases of LMWH-induced skin necrosis, emphasising the pathogenesis, clinical pattern, and management of this rare side effect.
Methods
We performed a Medline literature search (PubMed database) and manual cross-referencing to identify all articles related to LMWH-induced skin necrosis. Data were analysed for type of LMWH used, time until skin necrosis occurred, localisation, size, laboratory findings, switch anticoagulant, complications, and outcome. Additionally, the case of a patient from our hospital is presented.
Results
We included a total of 20 articles (21 cases) reporting on LMWH-induced skin necrosis. Skin necrosis occurred locally and distant from the injection site. Heparin-induced antibodies were frequently observed (positive 9/11 articles, negative 2/11). However, severe thrombocytopenia (platelet count <100,000 cells/ml) occurred in only four cases, while platelet count remained normal in 50% of the cases. After patients had been switched to other anti-thrombotic drugs, the clinical course was usually benign; however, reconstructive surgery was necessary in two cases.
Conclusion
LMWH-induced skin necrosis may occur as part of the heparin-induced thrombocytopenia (HIT) syndrome, but other pathomechanisms, including allergic reactions and local trauma, may also be involved. When HIT is excluded, unfractionated heparin is a safe switch anticoagulant. Otherwise, non-heparin preparations such as hirudin or fondaparinux should be preferred.
Similar content being viewed by others
References
Geerts WH, Anderson JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB (2001) Prevention of venous thromboembolism. Chest 119:132–175, 259–265
Hull RD, Pineo GF, Stein P, Mah A, MacIsaac SM, Dahl O, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE (2001) Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 135:858–869
Kakkar VV, Cohen AT, Edmonson RA, Phillips MJ, Cooper DJ, Das SK, Maher KT, Sanderson RM, Ward VP, Kakkar S (1993) Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group. Lancet 30:259–265
Litin SC, Heit JA, Mees KA (1998) Use of low molecular weight heparin in the treatment of venous thromboembolic disease: answers to frequently asked questions. Mayo Clin Proc 73:540–550
Leizorovicz A, Simonneau G, Decousus H, Boissel JP (1994) Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ 309:299–304
Walenga JM, Bick RL (1998) Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy. Med Clin North Am 82:635–658
Warkentin T (2003) Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121:535–555
Wutschert R, Piletta P, Bounameaux H (1999) Adverse skin reactions to low molecular weight heparins: frequency, management and prevention. Drug Saf 20:515–525
McAlister FA, Clark HD, van Walraven C, Straus SE, Lawson FM, Mosher D, Mulrow CD (1999) The medical review article revisited: has the science improved? Ann Intern Med 131:947–951
Cordoliani F, Saiag P, Guillaume JC, Roujeau JC, Wechsler J, Clerici T, Touraine R (1987) Necroses cutanees etendues induites par la fraxiparine (in French). Ann Dermatol Venereol 114:1366–1368
Montserrat I, Lopez D, Zuazu-Jausoro I, Mateo J, Ribera L, Souto JC, Falcon L, Fontcuberta J (1990) Low molecular weight heparin induced skin necrosis. Blood Coagul Fibrinolysis 1:751–752
Ojeda E, Perez MC, Mataix R, Arbalo A, Jimenez S, Campo C, Bal-Da I (1992) Skin necrosis with a low molecular weight heparin. Br J Haematol 82:620
Balestra B, Quadri P, Dermarmels-Biasiutti F, Furlan M, Lämmle B (1994) Low molecular weight heparin-induced thrombocytopenia and skin necrosis distant from injection sites. Eur J Haematol 53:61–63
Koch P, Wagner S, Baum HP (1994) Necroses cutanees a l’heparine et deficit en protein C? Ann Dermatol Venereol 121[Suppl 1]:122
Real E, Grau E, Rubio M, Torrecilla T (1995) Skin necrosis after subcutaneous low molecular weight heparin injection. Am J Hematol 49:253–254
Fried M, Kahanovich S, Dagan R (1996) Enoxaparin-induced skin necrosis. Ann Intern Med 125:521–522
Lefebre I, Delaporte E, Dejobert Y, Catteau B, Piette F, Bergoend H (1997) Enoxaparin-induced cutaneous necrosis localized on insulin lipodystrophies (in French). Ann Dermatol Venereol 124:397–400
Gibson GE, Gibson LE, Drage LA, Garret CR, Gertz MA (1997) Skin necrosis secondary to low molecular weight heparin in a patient with antiphospholipid antibody syndrome. J Am Acad Dermatol 37:855–859
Tietge UJF, Schmidt HH, Jäckel C, Trautwein C, Manns MP (1998) LMWH-induced skin necrosis occurring distant from injection sites and without thrombopenia. J Intern Med 243:313–315
Tonn ME, Schaiff RA, Kollef MH (1997) Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies. Ann Pharmacother 31:323–326
Plath J, Schulze R, Barz D, Krammer B, Steiner M, Anders O, Mach J (1997) Necrotizing skin lesions induced by low molecular weight heparin after total knee arthroplasty. Arch Orthop Trauma Surg 116:443–445
Fureder W, Kyrle PA, Gisslinger H, Lechner K (1998) LMWH-induced skin necrosis. Ann Haematol 77:127–130
Santamaria A, Romani J, Souto JC, Lopez A, Mateo J, Fontcuberta J (1998) Skin necrosis at the injection site induced by low molecular weight heparin: case report and review. Dermatology 196:264–265
Drew PJ, Smith MJ, Milling MA (1999) Heparin-induced skin necrosis and low molecular weight heparins. Ann R Coll Surg Engl 81:266–269
Walder A, Hättenschwiler A, Helfenstein E, Vogt M (2001) Massive Hautnekrosen nach Dalteparin Injektion (in German). Schweiz Med Forum 20/30:773–774
Ang KL, Bose A, Halil O, Cummins D, Amrani M (2003) Low molecular weight heparin (LMWH)-induced skin necrosis in a patient with unstable angina. Int J Cardiol 91:239–240
Payne SM, Kovacs MJ (2003) Cutaneous dalteparin reactions associated with antibodies of heparin-induced thrombocytopenia. Ann Pharmacother 37:655–657
Fontana B, Bodmer A, Gruel Y, Boehlen F, Janer V, Kaya G, Righini M (2004) Skin necrosis is a clinical manifestation of low molecular weight heparin-induced thrombocytopenia. Thromb Haemost 91:196–197
Harenberg J, Hoffmann U, Huhle G, Winkler M, Bayerl C (2001) Cutaneous reactions to anticoagulants. Recognition and management. Am J Clin Dermatol 2:69–75
Ulrick PJ, Manoharan A (1984) Heparin-induced skin reaction. Med J Aust 140:287–289
Lim KB, Tan T (1986) Skin necrosis as a complication of improperly administered subcutaneous heparin. Singapore Med J 27:356–357
Warkentin TE, Elavathil LJ, Hayward CP, Johnston MA, Russett JI, Kelton JG (1997) The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 127:804–812
Warkentin TE (2001) Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis. Ann Intern Med 135:589–593
Mudaliar JH, Liem TK, Nichols WK, Spadone DP, Silver D (2001) Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies. J Vasc Surg 34:17–20
Hirsh J, Heddle N, Kelton JG (2004) Treatment of heparin-induced thrombocytopenia—a critical review. Arch Intern Med 164:361–369
Amiral J, Lormeau JC, Marfaing-Koka A, Vissac AM, Wolf M, Boyer-Neumann C, Tardy B, Herbert JM, Meyer D (1997) Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin–PF4 complexes developed in heparin-induced thrombocytopenia. Blood Coagul Fibrinolysis 8:114–117
Parody R, Oliver A, Souto JC, Fontcuberta J (2003) Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 88:ECR32
Acknowledgements
The authors thank PD Dr. T. Bombeli, Division of Haematology, Department of Internal Medicine, University Hospital of Zurich, for assistance and correction of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Handschin, A.E., Trentz, O., Kock, H.J. et al. Low molecular weight heparin-induced skin necrosis—a systematic review. Langenbecks Arch Surg 390, 249–254 (2005). https://doi.org/10.1007/s00423-004-0522-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-004-0522-7